AAAAAA

   
Results: 1-7 |
Results: 7
SUSTAINED-RELEASE ALFUZOSIN, FINASTERIDE AND THE COMBINATION OF BOTH IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
Authors: DEBRUYNE FMJ JARDIN A COLLOI D RESEL L WITJES WPJ DELAUCHECAVALLIER MC MCCARTHY C GEFFRIAUDRICOUARD C
Citation: Fmj. Debruyne et al., SUSTAINED-RELEASE ALFUZOSIN, FINASTERIDE AND THE COMBINATION OF BOTH IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA, European urology, 34(3), 1998, pp. 169-175
EFFICACY AND SAFETY OF SUSTAINED-RELEASE ALFUZOSIN 5 MG IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA
Authors: BUZELIN JM ROTH S GEFFRIAUDRICOUARD C DELAUCHECAVALLIER MC COULANGE C DELMAS V JACQUMIN D JUNG JL HODE E TENAILLON M TOUBOL J DELAERE PJ CORBUSIER A DJURHUNS JC NERSTROM B HERZIG J HENKE G GROTHUESMAN H WEGE B KUTSCHER KR KOCHS K TIETZE M ALBRECHT J SCHONHERR G QUAST D VARDAKIS G PREISS H BASSIRI AM KUHN E PILASKI K WINKLER WP KNUPFER E WULSCH E MATZ HJ WULFF HJ WITTKOWSKY K SCHUTT W SIMON J BOHM G COORS H WIDJAJA F SIEGMUND H SCHMIDT JM KRAUSE U ENGELS KG BRICKENKAMP A HEISING J SCHAEFER RM NELLES P
Citation: Jm. Buzelin et al., EFFICACY AND SAFETY OF SUSTAINED-RELEASE ALFUZOSIN 5 MG IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA, European urology, 31(2), 1997, pp. 190-198
CLINICAL UROSELECTIVITY - EVIDENCE FROM PATIENTS TREATED WITH SLOW-RELEASE ALFUZOSIN FOR SYMPTOMATIC BENIGN PROSTATIC OBSTRUCTION
Authors: BUZELIN JM DELAUCHECAVALLIER MC ROTH S GEFFRIAUDRICOUARD C SANTONI JP
Citation: Jm. Buzelin et al., CLINICAL UROSELECTIVITY - EVIDENCE FROM PATIENTS TREATED WITH SLOW-RELEASE ALFUZOSIN FOR SYMPTOMATIC BENIGN PROSTATIC OBSTRUCTION, British Journal of Urology, 79(6), 1997, pp. 898-904
DEMOGRAPHIC AND INCIDENCE STUDY OF CHRONI C-RENAL-FAILURE IN THE ILE-DE-FRANCE DISTRICT
Authors: JUNGERS P GIRAUD E CHAUVEAU P GEFFRIAUDRICOUARD C MAN NK ALTMAN JJ JACOBS C GRUNFELD JP
Citation: P. Jungers et al., DEMOGRAPHIC AND INCIDENCE STUDY OF CHRONI C-RENAL-FAILURE IN THE ILE-DE-FRANCE DISTRICT, Nephrologie, 17(8), 1996, pp. 429-434
RANDOMIZED PLACEBO-CONTROLLED TRIAL OF RECOMBINANT INTERLEUKIN-2 IN CHRONIC UREMIC PATIENTS, NONRESPONDERS TO HEPATITIS-B VACCINATION
Authors: JUNGERS P GEFFRIAUDRICOUARD C DAHMANE D FESSI H JUQUEL JP SIMON N DESCHAMPS A MEYRIER A
Citation: P. Jungers et al., RANDOMIZED PLACEBO-CONTROLLED TRIAL OF RECOMBINANT INTERLEUKIN-2 IN CHRONIC UREMIC PATIENTS, NONRESPONDERS TO HEPATITIS-B VACCINATION, Kidney international, 47(5), 1995, pp. 1483-1483
RELATION BETWEEN SERUM IGF-I AND ANEMIA IN PREDIALYSIS CHRONIC-RENAL-FAILURE PATIENTS
Authors: GEFFRIAUDRICOUARD C DIOUF B URENA P SOUBERBIELLE JC DRUEKE TB
Citation: C. Geffriaudricouard et al., RELATION BETWEEN SERUM IGF-I AND ANEMIA IN PREDIALYSIS CHRONIC-RENAL-FAILURE PATIENTS, Nephrology, dialysis, transplantation, 8(8), 1993, pp. 784-785
INEFFICACY AND TOXICITY OF PEFLOXACIN IN FOCAL AND SEGMENTAL GLOMERULOSCLEROSIS WITH STEROID-RESISTANT NEPHROTIC SYNDROME
Authors: GEFFRIAUDRICOUARD C JUNGERS P CHAUVEAU D GRUNFELD JP
Citation: C. Geffriaudricouard et al., INEFFICACY AND TOXICITY OF PEFLOXACIN IN FOCAL AND SEGMENTAL GLOMERULOSCLEROSIS WITH STEROID-RESISTANT NEPHROTIC SYNDROME, Lancet, 341(8858), 1993, pp. 1475-1475
Risultati: 1-7 |